Annual FCF
-$33.83 M
-$15.02 M-79.86%
31 December 2023
Summary:
Zevra Therapeutics annual free cash flow is currently -$33.83 million, with the most recent change of -$15.02 million (-79.86%) on 31 December 2023. During the last 3 years, it has fallen by -$31.86 million (-1615.57%). ZVRA annual FCF is now -427.28% below its all-time high of $10.34 million, reached on 31 December 2021.ZVRA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$18.14 M
+$968.00 K+5.07%
30 September 2024
Summary:
Zevra Therapeutics quarterly free cash flow is currently -$18.14 million, with the most recent change of +$968.00 thousand (+5.07%) on 30 September 2024. Over the past year, it has dropped by -$13.34 million (-277.94%). ZVRA quarterly FCF is now -209.80% below its all-time high of $16.52 million, reached on 01 June 2021.ZVRA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$69.64 M
-$13.34 M-23.69%
30 September 2024
Summary:
Zevra Therapeutics TTM free cash flow is currently -$69.64 million, with the most recent change of -$13.34 million (-23.69%) on 30 September 2024. Over the past year, it has dropped by -$47.55 million (-215.18%). ZVRA TTM FCF is now -690.21% below its all-time high of $11.80 million, reached on 01 June 2021.ZVRA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -79.9% | -277.9% | -215.2% |
| 3 y3 years | -1615.6% | -563.5% | -788.4% |
| 5 y5 years | +37.6% | -712.4% | -95.2% |
ZVRA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -427.3% | at low | -1997.2% | +5.1% | -773.7% | at low |
| 5 y | 5 years | -427.3% | +37.6% | -209.8% | +5.1% | -690.2% | at low |
| alltime | all time | -427.3% | +37.6% | -209.8% | +5.1% | -690.2% | at low |
Zevra Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$18.14 M(-5.1%) | -$69.64 M(+23.7%) |
| June 2024 | - | -$19.11 M(+18.2%) | -$56.30 M(+22.6%) |
| Mar 2024 | - | -$16.16 M(-0.4%) | -$45.92 M(+35.7%) |
| Dec 2023 | -$33.83 M(+79.9%) | -$16.23 M(+238.1%) | -$33.83 M(+53.1%) |
| Sept 2023 | - | -$4.80 M(-45.0%) | -$22.10 M(-7.6%) |
| June 2023 | - | -$8.73 M(+114.2%) | -$23.92 M(+23.9%) |
| Mar 2023 | - | -$4.07 M(-9.4%) | -$19.32 M(+2.7%) |
| Dec 2022 | -$18.81 M(-282.0%) | -$4.50 M(-32.1%) | -$18.81 M(+23.9%) |
| Sept 2022 | - | -$6.63 M(+60.9%) | -$15.18 M(+34.5%) |
| June 2022 | - | -$4.12 M(+15.4%) | -$11.29 M(-220.7%) |
| Mar 2022 | - | -$3.57 M(+312.6%) | $9.35 M(-9.5%) |
| Dec 2021 | $10.34 M(-624.2%) | - | - |
| Dec 2021 | - | -$865.00 K(-68.4%) | $10.34 M(+2.2%) |
| Sept 2021 | - | -$2.73 M(-116.5%) | $10.12 M(-14.3%) |
| June 2021 | - | $16.52 M(-738.9%) | $11.80 M(-567.3%) |
| Mar 2021 | - | -$2.59 M(+138.3%) | -$2.52 M(+28.0%) |
| Dec 2020 | -$1.97 M(-91.7%) | -$1.08 M(+3.2%) | -$1.97 M(-50.6%) |
| Sept 2020 | - | -$1.05 M(-147.8%) | -$3.99 M(-22.9%) |
| June 2020 | - | $2.20 M(-208.1%) | -$5.17 M(-64.8%) |
| Mar 2020 | - | -$2.03 M(-34.5%) | -$14.71 M(-38.1%) |
| Dec 2019 | -$23.76 M | -$3.10 M(+39.0%) | -$23.76 M(-33.4%) |
| Sept 2019 | - | -$2.23 M(-69.6%) | -$35.67 M(-27.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$7.34 M(-33.7%) | -$49.40 M(-3.5%) |
| Mar 2019 | - | -$11.08 M(-26.2%) | -$51.21 M(-5.6%) |
| Dec 2018 | -$54.22 M(+62.9%) | -$15.01 M(-5.9%) | -$54.22 M(+17.5%) |
| Sept 2018 | - | -$15.96 M(+74.4%) | -$46.15 M(+14.2%) |
| June 2018 | - | -$9.15 M(-35.1%) | -$40.40 M(+7.0%) |
| Mar 2018 | - | -$14.10 M(+103.2%) | -$37.76 M(+13.5%) |
| Dec 2017 | -$33.28 M(+9.4%) | -$6.94 M(-32.0%) | -$33.28 M(-7.0%) |
| Sept 2017 | - | -$10.21 M(+56.6%) | -$35.79 M(+4.7%) |
| June 2017 | - | -$6.52 M(-32.3%) | -$34.19 M(-5.3%) |
| Mar 2017 | - | -$9.62 M(+1.8%) | -$36.10 M(+18.7%) |
| Dec 2016 | -$30.41 M(+49.1%) | -$9.45 M(+9.8%) | -$30.41 M(+11.0%) |
| Sept 2016 | - | -$8.61 M(+2.1%) | -$27.41 M(+16.8%) |
| June 2016 | - | -$8.43 M(+114.4%) | -$23.47 M(+15.5%) |
| Mar 2016 | - | -$3.93 M(-39.0%) | -$20.31 M(-0.4%) |
| Dec 2015 | -$20.40 M(+38.6%) | -$6.44 M(+38.1%) | -$20.40 M(-2.6%) |
| Sept 2015 | - | -$4.67 M(-11.5%) | -$20.95 M(+3.8%) |
| June 2015 | - | -$5.27 M(+31.2%) | -$20.18 M(+13.1%) |
| Mar 2015 | - | -$4.02 M(-42.5%) | -$17.85 M(+21.3%) |
| Dec 2014 | -$14.72 M(+236.2%) | -$6.99 M(+79.5%) | -$14.72 M(+90.5%) |
| Sept 2014 | - | -$3.89 M(+32.4%) | -$7.73 M(+101.6%) |
| June 2014 | - | -$2.94 M(+229.7%) | -$3.83 M(+329.7%) |
| Mar 2014 | - | -$892.00 K | -$892.00 K |
| Dec 2013 | -$4.38 M | - | - |
FAQ
- What is Zevra Therapeutics annual free cash flow?
- What is the all time high annual FCF for Zevra Therapeutics?
- What is Zevra Therapeutics annual FCF year-on-year change?
- What is Zevra Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly FCF year-on-year change?
- What is Zevra Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Zevra Therapeutics?
- What is Zevra Therapeutics TTM FCF year-on-year change?
What is Zevra Therapeutics annual free cash flow?
The current annual FCF of ZVRA is -$33.83 M
What is the all time high annual FCF for Zevra Therapeutics?
Zevra Therapeutics all-time high annual free cash flow is $10.34 M
What is Zevra Therapeutics annual FCF year-on-year change?
Over the past year, ZVRA annual free cash flow has changed by -$15.02 M (-79.86%)
What is Zevra Therapeutics quarterly free cash flow?
The current quarterly FCF of ZVRA is -$18.14 M
What is the all time high quarterly FCF for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly free cash flow is $16.52 M
What is Zevra Therapeutics quarterly FCF year-on-year change?
Over the past year, ZVRA quarterly free cash flow has changed by -$13.34 M (-277.94%)
What is Zevra Therapeutics TTM free cash flow?
The current TTM FCF of ZVRA is -$69.64 M
What is the all time high TTM FCF for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM free cash flow is $11.80 M
What is Zevra Therapeutics TTM FCF year-on-year change?
Over the past year, ZVRA TTM free cash flow has changed by -$47.55 M (-215.18%)